The records of 129 pediatric patients who received a stem cell transplant between 2008 and 2011 were reviewed. Of these patients, 64 percent were readmitted within 180 days of the procedure.
The source of the transplanted cells was found to be linked to readmission rates— of the patients who received cells from a donor, 79 percent were readmitted at least once within six months. Of those who received their own cells, 38 percent were readmitted.
More Articles on Pediatric Quality:
Children’s of Alabama Reduces Chemotherapy Medication Errors by 50%
Study: Fast Tracking Pediatric Congenital Heart Surgery Patients Saves Time, Money
NIST Panel Expands Recommendations to Promote Pediatric EHR Adoption
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
